财新传媒
财新英文 > 要闻 > 正文

Cover Story: Chinese Medicine Injections Face Rigorous Regulation for the First Time

By Cui Xiaotian, Zhou Xinda and Denise Jia
2025年12月08日 05:04
New mandatory trials could eliminate two-thirds of all herbal injections, forcing a shift to modern scientific validation

The deaths first surfaced in a scattering of headlines: a toddler in Heilongjiang, a patient in Anhui, clusters of severe allergic reactions in hospitals across China. Each case shared one unsettling detail — the drug involved was a traditional Chinese medicine injection, a class of products used for decades, trusted by millions and supported by enormous sales.

  [财新双语通产品,是为有双语需求读者专门订制的优惠产品, 按此可享超值优惠订阅。]

责任编辑:Richard | 版面编辑:喻竹杨洋
财新网主编精选版电邮 样例
财新网新闻版电邮全新升级!财新网主编精心编写,每个工作日定时投递,篇篇重磅,可信可引。
订阅